Quick Answer
Celularity Inc reported Cash and Equivalents of $738.0 thousand for fiscal year 2024.
Celularity Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $738.0K | +225.1% |
| 2023 | $227.0K | -98.4% |
| 2022 | $13.97M | -62.5% |
| 2021 | $37.24M | -31.4% |
| 2020 | $54.31M | +5822.6% |
| 2019 | $917.0K | +3611.5% |
| 2018 | $24.7K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $120.0K | -9.8% | -86.1% |
| June 30, 2025 | $863.0K | +84.8% | +194.5% |
| March 31, 2025 | $293.0K | -84.6% | -60.3% |
| December 31, 2024 | $738.0K | +225.1% | +454.9% |
| September 30, 2024 | $133.0K | -51.3% | -71.5% |
| June 30, 2024 | $467.0K | -84.9% | -75.4% |
| March 31, 2024 | $1.90M | -77.7% | +737.9% |
| December 31, 2023 | $227.0K | -98.4% | -16.8% |
- Celularity Inc showed an increase of +225.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2024 period, Celularity Inc’s cash and equivalents has grown by 2887.0% (from $24.7 thousand to $738.0 thousand).
- The most recent figure is from Celularity Inc’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: